New York State Common Retirement Fund Avidity Biosciences, Inc. Transaction History
New York State Common Retirement Fund
- $68.1 Billion
- Q1 2025
A detailed history of New York State Common Retirement Fund transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 272,279 shares of RNA stock, worth $8.79 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
272,279
Previous 184,811
47.33%
Holding current value
$8.79 Million
Previous $5.37 Million
49.57%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding RNA
# of Institutions
253Shares Held
110MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$366 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$313 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$298 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$278 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$256 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.68B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...